We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




World’s First Portable Fingerprint Drug Test Launched

By LabMedica International staff writers
Posted on 13 Sep 2017
The world’s first portable fingerprint-based drug screening system has been launched and is available now. More...
The revolutionary system is hygienic and easy-to-use, collecting fingerprint samples in just five seconds and delivering simultaneous screening results in less than ten minutes for the four main drug groups: cocaine, opiates, cannabis and amphetamines.

Initial applications for the system include support for drug testing programs within drug rehabilitation, workplace and criminal justice arenas. Organizations using the new system, which have previously been reliant on collecting saliva and urine samples for drug screening, will benefit from the simplicity and improved hygiene of fingerprint drug tests. Those being tested appreciate the system’s dignified and non-invasive collection method.

The screening system is being launched by Intelligent Fingerprinting (Cambridge, UK). The technology which consists of a fingerprint sample collection cartridge and the portable Reader 1000 analysis unit works by analyzing the tiny traces of sweat contained in a fingerprint to detect drugs and drug metabolites. The four drug groups detected by Drug Screening Cartridge cover the majority of mainstream drug misuse, ensuring that the company’s new drug testing system can support a broad range of drug screening requirements immediately. Collecting a fingerprint sweat sample on the cartridge takes just five seconds. The cartridge is then inserted into a reader that analyses the fingerprint sweat to provide a positive or negative result for each drug in the test in less than 10 minutes.

Jerry Walker, PhD, CEO of Intelligent Fingerprinting, said, “Our portable fingerprint drug test means that organizations can now screen for drug use almost anywhere at any time. It only takes a few seconds to collect a fingerprint for analysis, and our revolutionary technology offers a much more hygienic and dignified means of testing compared with conventional drug tests that require bio-hazardous samples such as urine or saliva. Following successful UK market trials and validation, it’s clear that fingerprint samples are not only much easier to collect and process, but also deliver when it comes to the rigorous analysis required for drug use diagnostics.”

Related Links:
Intelligent Fingerprinting


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Slide Scanner System
NanoZoomer S540MD
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: The model combines digitized tumor histopathology, clinical variables, and a 42-gene molecular panel using AI to generate a unified recurrence risk prediction (Image Credit: Shutterstock)

Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing

Predicting which patients with early-stage breast cancer will develop distant recurrence remains difficult, complicating decisions about long-term therapy and surveillance. Widely used genomic assays are... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.